Net Sales Increased 4.2%, or 3.1%
Organic
Maintains Full Year Outlook
SHELTON,
Conn., Feb. 7, 2024 /PRNewswire/ --
Edgewell Personal Care Company (NYSE: EPC) today announced
results for its first fiscal quarter 2024 ended December 31,
2023.
Executive Summary
- Net sales were $488.9 million, an
increase of 4.2% compared to the prior year quarter.
- Organic net sales increased 3.1% (Organic basis excludes the
favorable impact from currency movements.)
- GAAP Diluted net Earnings Per Share ("EPS") were $0.09, compared to $0.24 in the prior year quarter.
- Adjusted EPS were $0.24, compared
to $0.32 in the prior year
quarter.
- Ended the first quarter with $214.2
million in cash on hand, access to an additional
$206.6 million revolving credit
facility and a net debt leverage ratio of 3.8x.
- Returned $22.6 million to
shareholders in the form of $15.0
million in share repurchases and $7.6
million of dividends in the first quarter.
- The Board of Directors declared a cash dividend of $0.15 per common share on February 1, 2024 for the first quarter.
The Company reports and forecasts results on a GAAP and
non-GAAP basis and has reconciled non-GAAP results and outlook to
the most directly comparable GAAP measures later in this release.
See non-GAAP Financial Measures for a more detailed explanation,
including definitions of various non-GAAP terms used in this
release. All comparisons used in this release are for the same
period in the prior fiscal year unless otherwise
stated.
"We had a good start to the fiscal year, with 3% organic net
sales growth, and notably strong performance across our
international markets, reflective of underlying volume growth and
further price execution. Gross margin was a highlight and above our
expectations, driven by our ability to realize further productivity
savings and gains from improved revenue management. With this good
start and strong fundamentals in place, we are on track to meet our
previous outlook for both top and bottom line." said Rod Little, Edgewell's President and Chief
Executive Officer. "Our performance reflects the changes we've
implemented across our organization, leading to more consistent
organic net sales growth, better operational execution, continued
efficiency in our supply chain, and increased brand investment
behind our strategic priorities. We believe continued focus on our
strategic priorities and strong execution positions us to deliver
significant value creation for our shareholders."
Fiscal 1Q 2024 Operating Results (Unaudited)
Net sales were $488.9
million in the quarter, an increase of 4.2%, including a
$5.5 million favorable impact from
currency movements. Organic net sales increased 3.1%, primarily
driven by strong performance in international markets across all
segments and reflecting growth from higher volumes and pricing
across Wet Shave and Grooming, partly offset by lower net sales in
North America. In aggregate,
organic net sales growth was driven by increased pricing, with
volumes essentially flat.
Gross profit was $197.7
million, as compared to $189.6
million in the prior year quarter. Gross margin as a
percent of net sales was 40.4%, flat compared to the prior year
quarter. Adjusted gross margin increased 30-basis points, as
productivity savings of approximately 380-basis points, the benefit
of higher pricing of approximately 210-basis points, and
approximately 70-basis points of favorable currency, more than
offset core gross inflationary pressures of approximately 70-basis
points, transitory cost headwinds related to unfavorable absorption
and heightened unit cost inflation trapped in inventory of
520-basis points and 40-basis points of negative mix and other.
Advertising and sales promotion expense
("A&P") was $48.2
million, or 9.9% of net sales, an increase of $2.3 million, compared to $45.9 million, or 9.8% of net sales in the prior
year quarter.
Selling, general and administrative expense
("SG&A") was $103.3
million, or 21.1% of net sales, as compared to $95.7 million, or 20.4% of net sales in the prior
year quarter. Adjusted SG&A as a percent of net sales increased
110-basis points, primarily driven by higher people and incentive
compensation expenses, and the impact of unfavorable currency
movements.
The Company recorded pre-tax restructuring and re-positioning
expenses of $6.8 million in the
quarter, consisting largely of severance and related costs in
support of cost efficiency programs, $0.7
million in acquisition and integration costs related to the
Billie acquisition, and $0.1 million
of other costs.
Operating income, was $26.1
million, inclusive of a $4.1
million favorable impact from currency movements, compared
to $31.9 million in the prior year
quarter. Adjusted operating income was $35.7
million, or 7.3% of net sales, compared to $37.3 million, or 8.0% of net sales in the prior
year quarter. Adjusted operating margin decreased 70-basis points,
or 150-basis points in constant currency, primarily reflecting
higher marketing and SG&A expenses.
Interest expense associated with debt was
$19.8 million, compared to
$19.9 million in the prior year
quarter. The decrease in interest expense was the result of a lower
overall debt balance on the Company's revolving credit facility,
partially offset by higher interest rates.
Other expense (income), net was $0.3 million of expense compared to $5.0 million of income in the prior year quarter.
The change compared to the prior year quarter was primarily driven
by lower foreign currency hedge gains.
The effective tax rate for the first quarter of fiscal
2024 was 20.1% compared to 27.0% in the prior year period. The
adjusted effective tax rate for the first quarter of fiscal 2024
was 22.8%, down from the prior year period adjusted effective tax
rate of 26.4%. The fiscal 2024 adjusted effective tax rate reflects
a more favorable mix of earnings in lower tax rate jurisdictions
compared to the prior year and the impact of a change in the
Company's prior estimates.
GAAP net earnings were $4.8
million or $0.09 per diluted
share compared to $12.4 million or
$0.24 per diluted share in the prior
year quarter. Adjusted net earnings were $12.0 million or $0.24 per share, compared to $16.5 million or $0.32 per share in the prior year quarter.
Currency movements in the quarter had no impact on adjusted EPS, as
the currency benefits within operating profit were offset by
currency-related losses included in other expense (income), net.
Adjusted EBITDA was $57.2 million,
inclusive of a $0.2 million
unfavorable currency impact, compared to $64.5 million in the prior year
quarter.
Net cash used by operating activities was
$72.9 million for the three
months ending December 31, 2023, compared to $86.3 million in the prior year period. The
decrease in cash used was largely driven by a lower net working
capital build.
Capital Allocation
On February 1, 2024, the Board of
Directors declared a quarterly cash dividend of $0.15 per common share for the first fiscal
quarter. The dividend will be payable on April 4, 2024, to shareholders of record as of
the close of business on March 7,
2024. During the first quarter of fiscal 2024, the Company
paid dividends totaling $7.6 million
to stockholders.
During the first quarter of fiscal 2024, the Company completed
share repurchases of approximately 0.4 million shares at a total
cost of $15.0 million. As of
December 31, 2023, the Company had 4.2 million shares of
common stock available for repurchase in the future under the
Board's 2018 authorization.
Fiscal 1Q 2024 Operating Segment Results (Unaudited)
Wet Shave (Men's Systems, Women's Systems, Disposables,
and Shave Preps)
Net sales increased $26.4 million,
or 9.6%. Organic net sales increased $22.4
million or 8.1%, reflecting growth across Men's and Women's
Systems, Disposables and Shave Preps. Sales were driven by strong
volume and price growth in most international markets, with notable
growth in key Asian markets. Wet Shave segment profit increased
$18.0 million, or 50.4%. Organic
segment profit, excluding the favorable impact from currency
increased $14.4 million, or 40.3%,
reflecting higher net sales and higher gross margins.
Sun and Skin Care (Sun
Care, Wet Ones, Bulldog, Jack
Black and Cremo)
Net sales increased $2.5 million,
or 2.2%. Organic net sales increased $1.0
million, or 0.9%, driven by mid-single-digit Sun Care growth across both North America and International markets,
partly offset by slightly lower sales in Men's Grooming and Wet
One's. Sun and Skin segment profit decreased $14.6 million. Organic segment profit decreased
$15.1 million primarily driven by
lower gross profit resulting from significantly higher inflation
related costs.
Feminine Care (Tampons, Pads, and Liners)
Net sales decreased $9.1 million,
or 11.2% with minimal currency impact, largely driven by a decline
in Tampons, reflective of the comparison to last year's competitive
product out-of-stocks and further retailer inventory reductions
this fiscal quarter. Segment profit decreased $4.6 million, or 38.7%. Organic segment profit
decreased $4.5 million, or 37.9%,
primarily driven by lower sales and the resulting impact on gross
profit.
Full Fiscal Year 2024 Financial Outlook
The Company is providing the following outlook assumptions for
fiscal 2024:
- Reported net sales are expected to increase in the range of
approximately 1% to 3%
- Includes an estimated 60-basis point negative impact from
currency movements
- Organic net sales are expected to increase approximately 2% to
4%
- GAAP EPS is expected to be in the range of $2.20 to $2.40
- Includes: Restructuring and re-positioning charges*,
Acquisition and integration costs, Sun
Care reformulation, and Other costs
- Adjusted EPS is expected to be in the range of $2.65 to $2.85
- Includes an estimated $0.20 EPS
unfavorable impact from foreign currency movements
- Adjusted gross margin is expected to increase approximately
80-basis points to the prior year
- The EPS outlook reflects the impact of share repurchases of
approximately $50 million
- Expect approximately 65% (previously 70%) of adjusted earnings
to be generated in the 2nd half of the fiscal year.
- Adjusted EBITDA is expected to be in the range of $340 to $352
million
- Includes an estimated $14 million
unfavorable impact from foreign currency changes
- Other Expense, net is expected to be approximately $3 million
- Interest expense associated with debt is expected to be
approximately $78 million
- Adjusted effective tax rate is expected to be approximately
22%
- Total depreciation and amortization expense expected to be
approximately $93 million
- Capital expenditures expected to be approximately 2.5% to 3.0%
of net sales
- Free cash flow is expected to be approximately $170 million
* In fiscal 2024, the Company is taking specific
actions to strengthen its operating model, simplify the
organization and improve manufacturing and supply chain
efficiency through restructuring and re-positioning actions. As a
result of these actions, the Company expects to incur pre-tax
charges of approximately $19 million
for the full fiscal year.
Webcast Information
In conjunction with this announcement, the Company will hold an
investor conference call beginning at 8:00
a.m. Eastern Time today. All interested parties may access a
live webcast of this conference call at www.edgewell.com, under the
"Investors," and "News and Events" tabs or by using the following
link: http://ir.edgewell.com/news-and-events/events
For those unable to participate during the live webcast, a
re-play will be available on www.edgewell.com, under the
"Investors," "Financial Reports," and "Quarterly Earnings" tabs.
This release includes references to the Company's website and
references to additional information and materials found on its
website. The Company's website and such information and materials
are not incorporated by reference in, and are not part of, this
release.
About Edgewell
Edgewell is a leading pure-play consumer products company with
an attractive, diversified portfolio of established brand names
such as Schick®, Wilkinson Sword® and Billie® men's and women's
shaving systems and disposable razors; Edge and Skintimate® shave
preparations; Playtex®, Stayfree®, Carefree® and o.b.® feminine
care products; Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack
Black®, and CREMO® sun and skin care products; and Wet Ones®
products. The Company has a broad global footprint and operates in
more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 6,800 employees
worldwide.
Forward-Looking Statements. This document contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. You should not place undue reliance on these
statements. Forward-looking statements generally can be identified
by the use of words or phrases such as "believe," "expect,"
"expectation," "anticipate," "may," "could," "intend," "belief,"
"estimate," "plan," "target," "predict," "likely," "will,"
"should," "forecast," "outlook," or other similar words or phrases.
These statements are not based on historical facts, but instead
reflect the Company's expectations, estimates or projections
concerning future results or events, including, without limitation,
the future earnings and performance of Edgewell or any of its
businesses. Many factors outside our control could affect the
realization of these estimates. These statements are not guarantees
of performance and are inherently subject to known and unknown
risks, uncertainties and assumptions that are difficult to predict
and could cause the Company's actual results to differ materially
from those indicated by those statements. The Company cannot assure
you that any of its expectations, estimates or projections will be
achieved. The forward-looking statements included in this document
are only made as of the date of this document and the Company
disclaims any obligation to publicly update any forward-looking
statement to reflect subsequent events or circumstances, except as
required by law. You should not place undue reliance on these
statements.
In addition, other risks and uncertainties not presently known
to the Company or that it presently considers immaterial could
significantly affect the accuracy of any such forward-looking
statements. Risks and uncertainties include those detailed from
time to time in the Company's publicly filed documents, including
in Item 1A. Risk Factors of Part I of the Company's Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
November 28, 2023.
Non-GAAP Financial Measures. While the Company reports
financial results in accordance with generally accepted accounting
principles ("GAAP") in the U.S., this discussion also includes
non-GAAP measures. These non-GAAP measures are referred to as
"adjusted" or "organic" and exclude items which are considered by
the Company as unusual or non-recurring and which may have a
disproportionate positive or negative impact on the Company's
financial results in any particular period. Reconciliations of
non-GAAP measures, including reconciliations of measures related to
the Company's fiscal 2024 financial outlook, are included within
the Notes to Condensed Consolidated Financial Statements included
with this release.
This non-GAAP information is provided as a supplement to, not as
a substitute for, or as superior to, measures of financial
performance prepared in accordance with GAAP. The Company uses this
non-GAAP information internally to make operating decisions and
believes it is helpful to investors because it allows more
meaningful period-to-period comparisons of ongoing operating
results. The information can also be used to perform analysis and
to better identify operating trends that may otherwise be masked or
distorted by the types of items that are excluded. This non-GAAP
information is a component in determining management's incentive
compensation. Finally, the Company believes this information
provides a higher degree of transparency. The following provides
additional detail on the Company's non-GAAP measures:
- The Company utilizes "adjusted" non-GAAP measures including
gross profit, SG&A, operating income, income taxes, net
earnings, diluted earnings per share, and EBITDA to internally make
operating decisions.
- Constant currency measures are calculated by removing the
impact of translational and transactional foreign currencies
changes, net of foreign currency hedges compared to the prior year.
Transactional foreign currency changes are driven by foreign legal
entities' transactions not denominated in local currency.
- The Company analyzes its net sales and segment profit on an
organic basis to better measure the comparability of results
between periods. Organic net sales and organic segment profit
exclude the impact of changes in foreign currency and the impact of
acquisitions.
- Segment profit will be impacted by fluctuations in translation
and transactional foreign currency. The impact of currency was
applied to segments using management's best estimate.
- Free cash flow is defined as net cash from operating
activities, less capital expenditures plus collections of deferred
purchase price of accounts receivable sold and proceeds from sales
of fixed assets. Free cash flow conversion is defined as free cash
flow as a percentage of net earnings adjusted for the net impact of
non-cash impairments.
- Net debt is defined as gross debt less cash. Net debt leverage
ratio is defined as net debt less cash divided by trailing twelve
month adjusted EBITDA.
Basis of Presentation. Please refer to the Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
November 28, 2023, for a revision of
previously issued consolidated financial statements, which may
impact year over year results or future estimates included in this
release.
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF EARNINGS
(unaudited, in
millions, except per share data)
|
|
|
Three Months
Ended
December
31,
|
|
2023
|
|
2022
|
Net sales
|
$
488.9
|
|
$
469.1
|
Cost of products
sold
|
291.2
|
|
279.5
|
Gross
profit
|
197.7
|
|
189.6
|
|
|
|
|
Selling, general and
administrative expense
|
103.3
|
|
95.7
|
Advertising and sales
promotion expense
|
48.2
|
|
45.9
|
Research and
development expense
|
13.3
|
|
13.4
|
Restructuring
charges
|
6.8
|
|
2.7
|
Operating
income
|
26.1
|
|
31.9
|
Interest expense
associated with debt
|
19.8
|
|
19.9
|
Other expense (income),
net
|
0.3
|
|
(5.0)
|
Earnings before
income taxes
|
6.0
|
|
17.0
|
Income tax
provision
|
1.2
|
|
4.6
|
Net
earnings
|
$
4.8
|
|
$
12.4
|
|
|
|
|
Earnings per
share:
|
|
|
|
Basic net earnings per share
|
$
0.10
|
|
$
0.24
|
Diluted net earnings per diluted share
|
$
0.09
|
|
$
0.24
|
|
|
|
|
Weighted-average
shares outstanding:
|
|
|
|
Basic
|
50.1
|
|
51.6
|
Diluted
|
50.5
|
|
51.9
|
|
|
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED BALANCE SHEETS
(unaudited, in
millions)
|
|
|
|
|
|
December 31,
2023
|
|
September
30,
2023
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
214.2
|
|
$
216.4
|
Trade receivables,
less allowance for doubtful accounts
|
112.5
|
|
106.2
|
Inventories
|
521.9
|
|
492.4
|
Other current
assets
|
156.9
|
|
147.4
|
Total current
assets
|
1,005.5
|
|
962.4
|
Property, plant and
equipment, net
|
333.5
|
|
337.9
|
Goodwill
|
1,337.1
|
|
1,331.4
|
Other intangible
assets, net
|
970.1
|
|
973.8
|
Other assets
|
141.0
|
|
135.2
|
Total
assets
|
$
3,787.2
|
|
$
3,740.7
|
|
|
|
|
Liabilities and
Shareholders' Equity
|
|
|
|
Current
liabilities
|
|
|
|
Notes
payable
|
$
24.2
|
|
$
19.5
|
Accounts
payable
|
197.5
|
|
194.4
|
Other current
liabilities
|
246.0
|
|
309.5
|
Total current
liabilities
|
467.7
|
|
523.4
|
Long-term
debt
|
1,452.3
|
|
1,360.7
|
Deferred income tax
liabilities
|
136.9
|
|
136.4
|
Other
liabilities
|
184.5
|
|
179.7
|
Total
liabilities
|
2,241.4
|
|
2,200.2
|
Shareholders'
equity
|
|
|
|
Common
shares
|
0.7
|
|
0.7
|
Additional paid-in
capital
|
1,568.9
|
|
1,593.8
|
Retained
earnings
|
1,019.3
|
|
1,022.1
|
Common shares in
treasury at cost
|
(896.6)
|
|
(906.1)
|
Accumulated other
comprehensive loss
|
(146.5)
|
|
(170.0)
|
Total shareholders'
equity
|
1,545.8
|
|
1,540.5
|
Total liabilities
and shareholders' equity
|
$
3,787.2
|
|
$
3,740.7
|
|
|
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in
millions)
|
|
|
|
Three Months
Ended
December 31,
|
|
2023
|
|
2022
|
Cash Flow from
Operating Activities
|
|
|
|
Net
earnings
|
$
4.8
|
|
$
12.4
|
Depreciation and
amortization
|
22.5
|
|
22.5
|
Share-based
compensation expense
|
7.0
|
|
6.5
|
Loss on sale of
assets
|
0.1
|
|
0.7
|
Deferred compensation
payments
|
(0.4)
|
|
—
|
Deferred income
taxes
|
(0.2)
|
|
(0.1)
|
Other, net
|
(0.6)
|
|
(1.8)
|
Changes in current
assets and liabilities used in operations
|
(106.1)
|
|
(126.5)
|
Net cash used by
operating activities
|
$
(72.9)
|
|
$
(86.3)
|
|
|
|
|
Cash Flow from
Investing Activities
|
|
|
|
Capital
expenditures
|
$
(6.5)
|
|
$
(11.3)
|
Collection of deferred
purchase price on accounts receivable sold
|
—
|
|
0.4
|
Other, net
|
0.5
|
|
(0.3)
|
Net cash used by
investing activities
|
$
(6.0)
|
|
$
(11.2)
|
|
|
|
|
Cash Flow from
Financing Activities
|
|
|
|
Cash proceeds from
debt with original maturities greater than 90 days
|
$
216.0
|
|
$
241.0
|
Cash payments on debt
with original maturities greater than 90 days
|
(125.0)
|
|
(141.0)
|
Proceeds from debt
with original maturities of 90 days or less
|
4.1
|
|
5.5
|
Repurchase of
shares
|
(15.0)
|
|
(15.0)
|
Dividends to common
shareholders
|
(7.6)
|
|
(8.3)
|
Net financing inflow
from the Accounts Receivable Facility
|
4.8
|
|
8.8
|
Employee shares
withheld for taxes
|
(7.0)
|
|
(8.1)
|
Other, net
|
(0.5)
|
|
—
|
Net cash from financing
activities
|
$
69.8
|
|
$
82.9
|
|
|
|
|
Effect of exchange rate
changes on cash
|
6.9
|
|
10.0
|
|
|
|
|
Net decrease in cash
and cash equivalents
|
(2.2)
|
|
(4.6)
|
Cash and cash
equivalents, beginning of period
|
216.4
|
|
188.7
|
Cash and cash
equivalents, end of period
|
$
214.2
|
|
$
184.1
|
|
|
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL CARE COMPANY
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited,
in millions, except per share data)
Note 1 — Segments
The Company conducts its business in the following three
segments: Wet Shave, Sun and Skin Care, and Feminine Care
(collectively, the "Segments," and each individually, a "Segment").
Segment performance is evaluated based on segment profit, exclusive
of general corporate expenses, share-based compensation costs,
items which are considered by the Company to be unusual or
non-recurring and which may have a disproportionate positive or
negative impact on the Company's financial results in any
particular period and the amortization of intangible assets.
Financial items, such as interest income and expense, are managed
on a global basis at the corporate level. The exclusion of such
charges from segment results reflects management's view on how it
evaluates segment performance.
Segment net sales and profitability are presented below:
|
Three Months
Ended
December 31,
|
|
2023
|
|
2022
|
Net
Sales
|
|
|
|
Wet Shave
|
$
301.7
|
|
$
275.3
|
Sun and Skin
Care
|
115.4
|
|
112.9
|
Feminine
Care
|
71.8
|
|
80.9
|
Total net
sales
|
$
488.9
|
|
$
469.1
|
|
|
|
|
Segment
Profit
|
|
|
|
Wet Shave
|
$
53.7
|
|
$
35.7
|
Sun and Skin
Care
|
(1.3)
|
|
13.3
|
Feminine
Care
|
7.3
|
|
11.9
|
Total segment
profit
|
59.7
|
|
60.9
|
General corporate and
other expenses
|
(16.2)
|
|
(15.9)
|
Amortization of
intangibles
|
(7.8)
|
|
(7.7)
|
Interest and other
expense, net
|
(20.1)
|
|
(14.9)
|
Restructuring and
related costs
|
(6.8)
|
|
(2.8)
|
Acquisition and
integration costs
|
(0.7)
|
|
(2.1)
|
Sun Care reformulation
costs
|
(0.5)
|
|
(0.5)
|
Wet Ones manufacturing
plant fire
|
(1.5)
|
|
—
|
Other project
costs
|
(0.1)
|
|
—
|
Total earnings
before income taxes
|
$
6.0
|
|
$
17.0
|
Refer to Note 2 - GAAP to Non-GAAP Reconciliations for the
income statement location of non-GAAP adjustments to earnings
before income taxes.
Note 2 — GAAP to Non-GAAP Reconciliations
The following tables provide a GAAP to Non-GAAP reconciliation
of certain line items from the Condensed Consolidated Statement of
Earnings:
|
Three Months Ended
December 31, 2023
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT
(1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 197.7
|
|
$ 103.3
|
|
$ 26.1
|
|
$
6.0
|
|
$
1.2
|
|
$
4.8
|
|
$
0.09
|
Restructuring and
related costs
|
—
|
|
—
|
|
6.8
|
|
6.8
|
|
1.7
|
|
5.1
|
|
0.11
|
Acquisition and
integration costs
|
—
|
|
0.7
|
|
0.7
|
|
0.7
|
|
0.2
|
|
0.5
|
|
0.01
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
0.5
|
|
0.5
|
|
0.1
|
|
0.4
|
|
0.01
|
Wet Ones manufacturing
plant fire
|
1.5
|
|
—
|
|
1.5
|
|
1.5
|
|
0.4
|
|
1.1
|
|
0.02
|
Other project
costs
|
—
|
|
0.1
|
|
0.1
|
|
0.1
|
|
—
|
|
0.1
|
|
—
|
Total Adjusted
Non-GAAP
|
$ 199.2
|
|
$ 102.5
|
|
$ 35.7
|
|
$
15.6
|
|
$
3.6
|
|
$ 12.0
|
|
$
0.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
0.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
40.4 %
|
|
21.1 %
|
|
5.3 %
|
|
GAAP effective tax
rate
|
20.1 %
|
|
|
Adjusted as a percent
of net sales
|
40.7 %
|
|
21.0 %
|
|
7.3 %
|
|
Adjusted effective tax
rate
|
22.8 %
|
|
|
Adjusted Constant
Currency as a
percent of net sales
|
40.0 %
|
|
|
|
6.5 %
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31, 2022
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT
(1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 189.6
|
|
$ 95.7
|
|
$ 31.9
|
|
$
17.0
|
|
$
4.6
|
|
$ 12.4
|
|
$
0.24
|
Restructuring and
related costs
|
—
|
|
0.1
|
|
2.8
|
|
2.8
|
|
0.7
|
|
2.1
|
|
0.04
|
Acquisition and
integration costs
|
—
|
|
2.1
|
|
2.1
|
|
2.1
|
|
0.5
|
|
1.6
|
|
0.03
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
0.5
|
|
0.5
|
|
0.1
|
|
0.4
|
|
0.01
|
Total Adjusted
Non-GAAP
|
$ 189.6
|
|
$ 93.5
|
|
$ 37.3
|
|
$
22.4
|
|
$
5.9
|
|
$ 16.5
|
|
$
0.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
40.4 %
|
|
20.4 %
|
|
6.8 %
|
|
GAAP effective tax
rate
|
27.0 %
|
|
|
Adjusted as a percent
of net sales
|
40.4 %
|
|
19.9 %
|
|
8.0 %
|
|
Adjusted effective tax
rate
|
26.4 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) EBIT is defined as
Earnings before Income taxes.
|
Note 3 - Net Sales and Profit by Segment
Operations for the Company are reported via three Segments. The
following tables present changes in net sales and segment profit
for the three months ended December 31, 2023, as compared
to the corresponding period in the prior year quarter.
Net
Sales
|
Quarter Ended
December 31, 2023
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - Q1
FY23
|
$
275.3
|
|
|
|
$
112.9
|
|
|
|
$ 80.9
|
|
|
|
$
469.1
|
|
|
Organic
|
22.4
|
|
8.1 %
|
|
1.0
|
|
0.9 %
|
|
(9.1)
|
|
(11.2) %
|
|
14.3
|
|
3.1 %
|
Impact of
currency
|
4.0
|
|
1.5 %
|
|
1.5
|
|
1.3 %
|
|
—
|
|
— %
|
|
5.5
|
|
1.1 %
|
Net Sales - Q1
FY24
|
$
301.7
|
|
9.6 %
|
|
$
115.4
|
|
2.2 %
|
|
$ 71.8
|
|
(11.2) %
|
|
$
488.9
|
|
4.2 %
|
Segment
Profit
|
Quarter Ended
December 31, 2023
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit - Q1
FY23
|
$ 35.7
|
|
|
|
$ 13.3
|
|
|
|
$ 11.9
|
|
|
|
$ 60.9
|
|
|
Organic
|
14.4
|
|
40.3 %
|
|
(15.1)
|
|
(113.6) %
|
|
(4.5)
|
|
(37.9) %
|
|
(5.2)
|
|
(8.6) %
|
Impact of
currency
|
3.6
|
|
10.1 %
|
|
0.5
|
|
3.8 %
|
|
(0.1)
|
|
(0.8) %
|
|
4.0
|
|
6.6 %
|
Segment Profit - Q1
FY24
|
$ 53.7
|
|
50.4 %
|
|
$ (1.3)
|
|
(109.8) %
|
|
$ 7.3
|
|
(38.7) %
|
|
$ 59.7
|
|
(2.0) %
|
For all tables, the impact of currency to segment profit
includes both the translational and transactional currency changes
during the quarter.
Note 4 - Net Debt and EBITDA
The Company reports financial results on a GAAP and adjusted
basis. The tables below are used to reconcile Net Debt and Net
earnings to EBITDA and Adjusted EBITDA, which are Non-GAAP
measures, to improve comparability of results between periods.
|
December 31,
2023
|
|
September
30,
2023
|
Notes
payable
|
$
24.2
|
|
$
19.5
|
Long-term
debt
|
1,452.3
|
|
1,360.7
|
Gross debt
|
$
1,476.5
|
|
$
1,380.2
|
Less: Cash and cash
equivalents
|
214.2
|
|
216.4
|
Net Debt
|
$
1,262.3
|
|
$
1,163.8
|
|
Three Months
Ended
December
31,
|
|
2023
|
|
2022
|
Net
earnings
|
$
4.8
|
|
$
12.4
|
Income tax
provision
|
1.2
|
|
4.6
|
Interest expense,
net
|
19.1
|
|
19.6
|
Depreciation and
amortization
|
22.5
|
|
22.5
|
EBITDA
|
$
47.6
|
|
$
59.1
|
|
|
|
|
Restructuring and
related costs
|
6.8
|
|
2.8
|
Acquisition and
integration costs
|
0.7
|
|
2.1
|
Sun Care reformulation
costs
|
0.5
|
|
0.5
|
Wet Ones manufacturing
plant fire
|
1.5
|
|
—
|
Other costs
|
0.1
|
|
—
|
Adjusted
EBITDA
|
$
57.2
|
|
$
64.5
|
|
|
|
|
Adjusted EBITDA
Constant Currency
|
$
57.4
|
|
|
Note 5 - Outlook
The following tables provide reconciliations of Adjusted EPS and
Adjusted EBITDA, Non-GAAP measures, included within the Company's
outlook for projected fiscal 2024 results:
Adjusted EPS
Outlook
|
|
|
Fiscal 2024 GAAP
EPS
|
approx.
|
$2.20 -
$2.40
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
0.37
|
Acquisition and
integration costs
|
approx.
|
0.05
|
Sun Care reformulation
costs
|
approx.
|
0.15
|
Other costs
|
approx.
|
0.03
|
Income
taxes(1)
|
approx.
|
(0.15)
|
|
|
|
Fiscal 2024 Adjusted
EPS Outlook (Non-GAAP)
|
approx.
|
$2.65 -
$2.85
|
|
|
|
|
(1) Income
tax effect of the adjustments to Fiscal 2024 GAAP EPS noted
above.
|
Adjusted EBITDA
Outlook
|
|
|
Fiscal 2024 GAAP Net
Income
|
approx.
|
$109 - $121
|
Income tax
provision
|
approx.
|
31
|
Interest expense,
net
|
approx.
|
75
|
Depreciation and
amortization
|
approx.
|
93
|
EBITDA
|
approx.
|
$308 - $320
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
19
|
Acquisition and
integration costs
|
approx.
|
3
|
Sun Care reformulation
costs
|
approx.
|
8
|
Other costs
|
approx.
|
2
|
Fiscal 2024 Adjusted
EBITDA
|
approx.
|
$340 - $352
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-first-quarter-fiscal-2024-results-302055333.html
SOURCE Edgewell Personal Care Company